Biotechnology
The Biotechnology industry has a total of 591 stocks, with a combined market cap of $1.19 trillion and total revenue of $110.17 billion.
Market Cap
1.19T
Revenue
110.17B
Profits
-39.86B
PE Ratio
n/a
Profit Margin
-36.19%
Dividend Yield
0.04%
591 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | VRTX | Vertex Pharmaceuticals Incorporated | 111.78B | 0.06% | 412,441 | 12.00B |
| 2 | REGN | Regeneron Pharmaceuticals, Inc. | 76.83B | -0.10% | 298,499 | 14.34B |
| 3 | ARGX | argenx SE | 51.85B | -2.67% | 200,687 | 4.24B |
| 4 | ALNY | Alnylam Pharmaceuticals, Inc. | 40.50B | -1.78% | 807,788 | 3.71B |
| 5 | ONC | BeOne Medicines AG | 34.83B | -1.25% | 92,776 | 5.34B |
| 6 | RVMD | Revolution Medicines, Inc. | 31.08B | 1.05% | 1,136,079 | - |
| 7 | INSM | Insmed Incorporated | 30.97B | 0.46% | 742,076 | 606.42M |
| 8 | RPRX | Royalty Pharma plc | 29.20B | -0.10% | 1,163,403 | 2.38B |
| 9 | BNTX | BioNTech SE | 27.93B | 4.98% | 1,732,645 | 3.37B |
| 10 | MRNA | Moderna, Inc. | 21.77B | 0.55% | 3,729,934 | 1.94B |
| 11 | ROIV | Roivant Sciences Ltd. | 20.95B | 0.65% | 1,393,595 | 13.31M |
| 12 | SMMT | Summit Therapeutics Inc. | 20.19B | 3.64% | 8,047,585 | - |
| 13 | INCY | Incyte Corporation | 19.25B | -0.19% | 627,641 | 5.14B |
| 14 | GMAB | Genmab A/S | 16.74B | -2.47% | 3,139,148 | 3.72B |
| 15 | ASND | Ascendis Pharma A/S | 14.74B | -2.79% | 275,935 | 845.52M |
| 16 | BBIO | BridgeBio Pharma, Inc. | 14.62B | -1.68% | 684,835 | 502.08M |
| 17 | IONS | Ionis Pharmaceuticals, Inc. | 12.43B | 0.49% | 828,826 | 943.71M |
| 18 | JAZZ | Jazz Pharmaceuticals plc | 12.32B | -1.23% | 610,475 | 4.27B |
| 19 | MDGL | Madrigal Pharmaceuticals, Inc. | 12.21B | 0.98% | 93,152 | 958.40M |
| 20 | EXEL | Exelixis, Inc. | 11.51B | 3.90% | 1,940,796 | 2.32B |
| 21 | BMRN | BioMarin Pharmaceutical Inc. | 10.50B | -0.48% | 674,970 | 3.22B |
| 22 | ARWR | Arrowhead Pharmaceuticals, Inc. | 10.04B | 3.57% | 1,359,926 | 1.09B |
| 23 | PRAX | Praxis Precision Medicines, Inc. | 9.55B | 0.11% | 223,851 | 7.46M |
| 24 | TECH | Bio-Techne Corporation | 9.47B | -0.08% | 843,820 | 1.22B |
| 25 | AXSM | Axsome Therapeutics, Inc. | 9.42B | -2.45% | 381,790 | 638.50M |
| 26 | ABVX | ABIVAX Société Anonyme | 9.39B | -1.26% | 394,597 | 5.37M |
| 27 | PCVX | Vaxcyte, Inc. | 8.69B | -2.63% | 416,445 | - |
| 28 | IBRX | ImmunityBio, Inc. | 8.37B | -1.16% | 9,640,836 | 113.29M |
| 29 | NUVL | Nuvalent, Inc. | 8.36B | -1.79% | 415,026 | - |
| 30 | HALO | Halozyme Therapeutics, Inc. | 8.17B | -0.86% | 587,553 | 1.40B |
| 31 | CYTK | Cytokinetics, Incorporated | 8.13B | -0.18% | 466,492 | 88.04M |
| 32 | KRYS | Krystal Biotech, Inc. | 8.09B | -0.58% | 76,575 | 389.13M |
| 33 | KYMR | Kymera Therapeutics, Inc. | 7.14B | 0.54% | 275,770 | 39.21M |
| 34 | ERAS | Erasca, Inc. | 7.03B | 4.15% | 5,156,651 | - |
| 35 | ACLX | Arcellx, Inc. | 6.75B | - | 503,904 | 22.29M |
| 36 | PTGX | Protagonist Therapeutics, Inc. | 6.74B | 0.15% | 163,144 | 46.02M |
| 37 | APGE | Apogee Therapeutics, Inc. | 6.62B | -1.36% | 209,196 | - |
| 38 | BLTE | Belite Bio, Inc | 6.58B | 1.12% | 56,920 | - |
| 39 | CNTA | Centessa Pharmaceuticals plc | 6.11B | -0.05% | 1,845,284 | 15.00M |
| 40 | TERN | Terns Pharmaceuticals, Inc. | 6.10B | 0.10% | 2,507,574 | - |
| 41 | SYRE | Spyre Therapeutics, Inc. | 6.09B | -3.82% | 616,363 | - |
| 42 | CGON | CG Oncology, Inc. | 6.08B | 2.34% | 431,416 | 4.04M |
| 43 | CELC | Celcuity Inc. | 6.00B | 3.42% | 234,762 | - |
| 44 | CAI | Caris Life Sciences, Inc. | 5.96B | -0.66% | 1,161,721 | 812.03M |
| 45 | COGT | Cogent Biosciences, Inc. | 5.92B | -0.70% | 1,053,080 | - |
| 46 | PTCT | PTC Therapeutics, Inc. | 5.86B | -2.19% | 298,227 | 1.73B |
| 47 | RYTM | Rhythm Pharmaceuticals, Inc. | 5.77B | -3.69% | 255,313 | 189.76M |
| 48 | IMVT | Immunovant, Inc. | 5.76B | -0.84% | 649,707 | - |
| 49 | MIRM | Mirum Pharmaceuticals, Inc. | 5.73B | -0.71% | 182,579 | 521.31M |
| 50 | SRRK | Scholar Rock Holding Corporation | 5.53B | 0.77% | 795,073 | - |
| 51 | CRSP | CRISPR Therapeutics AG | 5.44B | -1.79% | 1,269,119 | 3.51M |
| 52 | TGTX | TG Therapeutics, Inc. | 5.37B | -1.54% | 1,084,738 | 616.29M |
| 53 | XENE | Xenon Pharmaceuticals Inc. | 5.34B | -1.91% | 263,041 | 7.50M |
| 54 | APLS | Apellis Pharmaceuticals, Inc. | 5.24B | -0.04% | 2,751,230 | 1.00B |
| 55 | DNTH | Dianthus Therapeutics, Inc. | 4.94B | -1.28% | 236,554 | 2.04M |
| 56 | CORT | Corcept Therapeutics Incorporated | 4.77B | -3.15% | 382,512 | 761.41M |
| 57 | LEGN | Legend Biotech Corporation | 4.63B | -0.04% | 2,657,213 | 1.03B |
| 58 | LGND | Ligand Pharmaceuticals Incorporated | 4.56B | -1.36% | 62,985 | 268.09M |
| 59 | FOLD | Amicus Therapeutics, Inc. | 4.54B | 0.03% | 1,559,223 | 634.21M |
| 60 | CRNX | Crinetics Pharmaceuticals, Inc. | 4.08B | -3.20% | 424,375 | 7.70M |
| 61 | TNGX | Tango Therapeutics, Inc. | 3.93B | 4.47% | 1,123,653 | 62.38M |
| 62 | VKTX | Viking Therapeutics, Inc. | 3.93B | -4.53% | 2,534,530 | - |
| 63 | NAMS | NewAmsterdam Pharma Company N.V. | 3.76B | -3.28% | 536,446 | 22.50M |
| 64 | ACAD | ACADIA Pharmaceuticals Inc. | 3.74B | -0.59% | 332,888 | 1.07B |
| 65 | TVTX | Travere Therapeutics, Inc. | 3.60B | -3.15% | 1,057,802 | 490.73M |
| 66 | TLX | Telix Pharmaceuticals Limited | 3.52B | -3.73% | 126,546 | 803.79M |
| 67 | EWTX | Edgewise Therapeutics, Inc. | 3.48B | -4.59% | 359,496 | - |
| 68 | ORKA | Oruka Therapeutics, Inc. | 3.43B | 0.57% | 367,407 | - |
| 69 | GPCR | Structure Therapeutics Inc. | 3.29B | -3.57% | 580,895 | - |
| 70 | ALMS | Alumis Inc. | 3.20B | 1.94% | 830,519 | 24.05M |
| 71 | DNLI | Denali Therapeutics Inc. | 3.20B | -1.70% | 523,916 | - |
| 72 | DYN | Dyne Therapeutics, Inc. | 3.18B | -3.80% | 1,165,498 | - |
| 73 | CPRX | Catalyst Pharmaceuticals, Inc. | 3.14B | -1.30% | 352,545 | 588.99M |
| 74 | BEAM | Beam Therapeutics Inc. | 3.07B | -0.93% | 928,914 | 139.74M |
| 75 | RLAY | Relay Therapeutics, Inc. | 3.01B | 2.56% | 1,183,034 | 15.36M |
| 76 | KLRA | Kailera Therapeutics, Inc. | 3.00B | -1.56% | 502,508 | - |
| 77 | ARQT | Arcutis Biotherapeutics, Inc. | 2.91B | -4.25% | 364,862 | 376.07M |
| 78 | RCUS | Arcus Biosciences, Inc. | 2.90B | 1.58% | 1,827,904 | 247.00M |
| 79 | KOD | Kodiak Sciences Inc. | 2.87B | 0.22% | 339,258 | - |
| 80 | VERA | Vera Therapeutics, Inc. | 2.85B | -4.52% | 324,025 | - |
| 81 | IDYA | IDEAYA Biosciences, Inc. | 2.82B | -4.37% | 866,541 | 218.71M |
| 82 | NKTR | Nektar Therapeutics | 2.81B | -2.24% | 1,031,835 | 55.23M |
| 83 | MANE | Veradermics, Incorporated | 2.76B | -0.15% | 79,388 | - |
| 84 | ZLAB | Zai Lab Limited | 2.75B | -3.47% | 733,336 | 460.16M |
| 85 | TARS | Tarsus Pharmaceuticals, Inc. | 2.74B | -2.24% | 391,797 | 451.36M |
| 86 | ELVN | Enliven Therapeutics, Inc. | 2.74B | -1.34% | 347,313 | - |
| 87 | SLNO | Soleno Therapeutics, Inc. | 2.73B | 0.06% | 1,175,060 | 190.41M |
| 88 | IMNM | Immunome, Inc. | 2.72B | -0.95% | 202,405 | 6.94M |
| 89 | CLDX | Celldex Therapeutics, Inc. | 2.67B | -0.90% | 352,671 | 1.55M |
| 90 | IRON | Disc Medicine, Inc. | 2.66B | -2.21% | 139,528 | - |
| 91 | ADMA | ADMA Biologics, Inc. | 2.50B | -1.29% | 2,427,587 | 510.17M |
| 92 | AAPG | Ascentage Pharma Group International | 2.42B | -3.30% | 4,061 | 82.08M |
| 93 | RARE | Ultragenyx Pharmaceutical Inc. | 2.36B | -3.91% | 657,923 | 673.00M |
| 94 | DFTX | Definium Therapeutics, Inc. | 2.35B | 1.77% | 1,750,916 | - |
| 95 | MLYS | Mineralys Therapeutics, Inc. | 2.31B | -6.65% | 596,946 | - |
| 96 | DAWN | Day One Biopharmaceuticals, Inc. | 2.22B | 0.02% | 692,133 | 158.18M |
| 97 | ADPT | Adaptive Biotechnologies Corporation | 2.20B | -2.06% | 723,096 | 276.98M |
| 98 | SRPT | Sarepta Therapeutics, Inc. | 2.18B | -3.13% | 1,588,687 | 2.20B |
| 99 | MESO | Mesoblast Limited | 2.13B | -1.81% | 122,023 | 65.38M |
| 100 | STOK | Stoke Therapeutics, Inc. | 2.11B | -1.95% | 210,170 | 184.42M |
| 101 | AUPH | Aurinia Pharmaceuticals Inc. | 2.09B | -1.44% | 329,676 | 283.06M |
| 102 | ZYME | Zymeworks Inc. | 2.07B | 0.86% | 226,210 | 105.97M |
| 103 | SNDX | Syndax Pharmaceuticals, Inc. | 2.05B | -2.31% | 493,885 | 172.35M |
| 104 | TRVI | Trevi Therapeutics, Inc. | 2.04B | -5.45% | 1,058,137 | - |
| 105 | OCUL | Ocular Therapeutix, Inc. | 2.02B | -2.52% | 1,880,234 | 51.95M |
| 106 | CAPR | Capricor Therapeutics, Inc. | 2.00B | 1.26% | 351,380 | 11.13M |
| 107 | TYRA | Tyra Biosciences, Inc. | 1.94B | 5.00% | 735,515 | - |
| 108 | GLPG | Galapagos NV | 1.93B | -0.53% | 108,889 | 1.31B |
| 109 | PHVS | Pharvaris N.V. | 1.92B | 1.31% | 43,832 | - |
| 110 | HRMY | Harmony Biosciences Holdings, Inc. | 1.91B | 11.72% | 2,561,050 | 868.45M |
| 111 | RXRX | Recursion Pharmaceuticals, Inc. | 1.91B | -2.17% | 7,483,356 | 74.68M |
| 112 | SION | Sionna Therapeutics, Inc. | 1.90B | -1.20% | 213,105 | - |
| 113 | PVLA | Palvella Therapeutics, Inc. | 1.87B | 0.84% | 135,122 | - |
| 114 | NTLA | Intellia Therapeutics, Inc. | 1.83B | 1.78% | 2,746,212 | 67.67M |
| 115 | NUVB | Nuvation Bio Inc. | 1.80B | 0.98% | 2,082,207 | 62.90M |
| 116 | TSHA | Taysha Gene Therapies, Inc. | 1.77B | -4.49% | 1,166,261 | 9.77M |
| 117 | ATAI | AtaiBeckley Inc. | 1.76B | -1.33% | 10,848,046 | 4.09M |
| 118 | RAPP | Rapport Therapeutics, Inc. | 1.75B | -1.59% | 241,245 | - |
| 119 | INVA | Innoviva, Inc. | 1.74B | -1.59% | 221,302 | 411.33M |
| 120 | VIR | Vir Biotechnology, Inc. | 1.74B | -1.94% | 692,879 | 68.56M |
| 121 | VCEL | Vericel Corporation | 1.73B | -5.17% | 390,204 | 276.26M |
| 122 | NRIX | Nurix Therapeutics, Inc. | 1.70B | -3.64% | 480,120 | 71.78M |
| 123 | OCS | Oculis Holding AG | 1.65B | -2.69% | 659,819 | 1.51M |
| 124 | GLUE | Monte Rosa Therapeutics, Inc. | 1.64B | 3.43% | 417,318 | 123.67M |
| 125 | DMRA | Damora Therapeutics, Inc. | 1.62B | 1.66% | 111,080 | - |
| 126 | NBTX | Nanobiotix S.A. | 1.59B | -4.48% | 84,872 | 38.27M |
| 127 | GENB | Generate Biomedicines, Inc. | 1.57B | 1.49% | 441,935 | 31.89M |
| 128 | AGIO | Agios Pharmaceuticals, Inc. | 1.55B | -2.14% | 647,280 | 54.03M |
| 129 | MBX | MBX Biosciences, Inc. | 1.55B | -3.67% | 208,220 | - |
| 130 | IMCR | Immunocore Holdings plc | 1.54B | -3.66% | 159,584 | 400.02M |
| 131 | BCAX | Bicara Therapeutics Inc. | 1.53B | -0.47% | 279,884 | - |
| 132 | ANAB | AnaptysBio, Inc. | 1.53B | 4.21% | 343,621 | 234.60M |
| 133 | BHVN | Biohaven Ltd. | 1.52B | -6.38% | 1,463,682 | - |
| 134 | IOVA | Iovance Biotherapeutics, Inc. | 1.52B | -2.25% | 8,131,183 | 263.50M |
| 135 | IMTX | Immatics N.V. | 1.51B | -0.09% | 148,233 | 56.67M |
| 136 | ARDX | Ardelyx, Inc. | 1.49B | -3.81% | 1,708,347 | 407.32M |
| 137 | VRDN | Viridian Therapeutics, Inc. | 1.46B | -2.59% | 854,147 | 70.85M |
| 138 | OLMA | Olema Pharmaceuticals, Inc. | 1.45B | 0.48% | 403,447 | - |
| 139 | CRVS | Corvus Pharmaceuticals, Inc. | 1.43B | 9.72% | 878,938 | - |
| 140 | WVE | Wave Life Sciences Ltd. | 1.42B | -2.57% | 2,475,963 | 42.73M |
| 141 | PGEN | Precigen, Inc. | 1.40B | -3.65% | 1,022,297 | 9.68M |
| 142 | NVAX | Novavax, Inc. | 1.39B | -1.73% | 2,143,452 | 1.12B |
| 143 | AVBP | ArriVent BioPharma, Inc. | 1.37B | -0.96% | 321,938 | - |
| 144 | SVRA | Savara Inc. | 1.36B | -4.10% | 593,945 | - |
| 145 | GHRS | GH Research PLC | 1.30B | -2.47% | 381,476 | - |
| 146 | MAZE | Maze Therapeutics, Inc. | 1.30B | -2.72% | 258,334 | 2.50M |
| 147 | MLTX | MoonLake Immunotherapeutics | 1.25B | -2.35% | 219,287 | - |
| 148 | DBVT | DBV Technologies S.A. | 1.25B | -4.36% | 305,916 | 5.64M |
| 149 | PHAR | Pharming Group N.V. | 1.24B | -2.11% | 4,017 | 376.13M |
| 150 | INBX | Inhibrx Biosciences, Inc. | 1.23B | 2.08% | 320,535 | 1.30M |
| 151 | ZBIO | Zenas BioPharma, Inc. | 1.23B | -1.20% | 144,979 | 10.00M |
| 152 | MPLT | MapLight Therapeutics, Inc. | 1.22B | -2.36% | 251,724 | - |
| 153 | EYPT | EyePoint, Inc. | 1.21B | -3.45% | 676,713 | 31.37M |
| 154 | URGN | UroGen Pharma Ltd. | 1.21B | -0.28% | 680,493 | 109.79M |
| 155 | ABCL | AbCellera Biologics Inc. | 1.19B | 0.77% | 2,783,636 | 75.13M |
| 156 | JBIO | Jade Biosciences, Inc. | 1.19B | 2.72% | 415,612 | - |
| 157 | IVA | Inventiva S.A. | 1.17B | -3.58% | 76,920 | 7.94M |
| 158 | SEPN | Septerna, Inc. | 1.16B | -3.65% | 149,613 | 45.95M |
| 159 | AKTS | Aktis Oncology, Inc. | 1.11B | -3.62% | 128,128 | 6.50M |
| 160 | ORIC | ORIC Pharmaceuticals, Inc. | 1.09B | -0.23% | 676,710 | - |
| 161 | QURE | uniQure N.V. | 1.08B | -4.66% | 622,145 | 16.10M |
| 162 | PHAT | Phathom Pharmaceuticals, Inc. | 1.04B | -2.82% | 754,344 | 175.11M |
| 163 | CTMX | CytomX Therapeutics, Inc. | 1.04B | -1.84% | 2,427,412 | 76.20M |
| 164 | XERS | Xeris Biopharma Holdings, Inc. | 1.03B | -4.23% | 814,453 | 291.85M |
| 165 | KALV | KalVista Pharmaceuticals, Inc. | 1.02B | -4.79% | 351,450 | 73.62M |
| 166 | SANA | Sana Biotechnology, Inc. | 1.01B | -3.93% | 2,527,302 | - |
| 167 | EVMN | Evommune, Inc. | 1.01B | -0.14% | 103,034 | 13.00M |
| 168 | ANNX | Annexon, Inc. | 999.76M | -3.11% | 908,074 | - |
| 169 | FTRE | Fortrea Holdings Inc. | 978.48M | 0.24% | 428,493 | 2.72B |
| 170 | JANX | Janux Therapeutics, Inc. | 959.32M | -0.63% | 1,264,694 | 10.00M |
| 171 | MGTX | MeiraGTx Holdings plc | 953.80M | -2.14% | 658,627 | 81.39M |
| 172 | OMER | Omeros Corporation | 951.07M | -1.93% | 465,370 | - |
| 173 | MRVI | Maravai LifeSciences Holdings, Inc. | 949.86M | 2.35% | 1,528,266 | 185.74M |
| 174 | CMPX | Compass Therapeutics, Inc. | 945.46M | -3.05% | 1,637,176 | 850.00K |
| 175 | GERN | Geron Corporation | 945.33M | -5.45% | 8,892,795 | 183.88M |
| 176 | XNCR | Xencor, Inc. | 924.07M | -1.56% | 136,035 | 125.58M |
| 177 | LBRX | LB Pharmaceuticals Inc | 919.89M | 1.29% | 179,301 | - |
| 178 | SLS | SELLAS Life Sciences Group, Inc. | 900.61M | 0.50% | 3,129,147 | - |
| 179 | ANRO | Alto Neuroscience, Inc. | 895.60M | -6.51% | 180,280 | - |
| 180 | ABUS | Arbutus Biopharma Corporation | 892.14M | -1.52% | 331,928 | 14.08M |
| 181 | DRUG | Bright Minds Biosciences Inc. | 882.87M | -4.76% | 141,348 | - |
| 182 | CGEM | Cullinan Therapeutics, Inc. | 865.52M | -1.52% | 353,292 | - |
| 183 | TBPH | Theravance Biopharma, Inc. | 862.51M | 0.18% | 240,494 | 107.46M |
| 184 | MNKD | MannKind Corporation | 852.28M | -5.48% | 2,473,359 | 348.97M |
| 185 | KURA | Kura Oncology, Inc. | 848.57M | -2.25% | 973,602 | 67.48M |
| 186 | SGP | SpyGlass Pharma, Inc. | 819.05M | -0.07% | 27,996 | - |
| 187 | FBRX | Forte Biosciences, Inc. | 818.55M | -2.88% | 115,228 | - |
| 188 | DSGN | Design Therapeutics, Inc. | 817.16M | 0.68% | 262,187 | - |
| 189 | VOR | Vor Biopharma Inc. | 813.87M | -4.39% | 806,782 | - |
| 190 | SLDB | Solid Biosciences Inc. | 807.82M | -3.30% | 554,194 | - |
| 191 | ALLO | Allogene Therapeutics, Inc. | 803.19M | -3.51% | 5,360,606 | 22.00K |
| 192 | LXRX | Lexicon Pharmaceuticals, Inc. | 794.40M | 1.90% | 815,475 | 49.80M |
| 193 | SPRY | ARS Pharmaceuticals, Inc. | 775.51M | -4.52% | 763,188 | 84.28M |
| 194 | CBIO | Crescent Biopharma, Inc. | 763.59M | 5.99% | 232,397 | 10.84M |
| 195 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 758.71M | 2.38% | 606,605 | - |
| 196 | RLMD | Relmada Therapeutics, Inc. | 754.15M | -2.44% | 1,321,242 | - |
| 197 | GYRE | Gyre Therapeutics, Inc. | 733.25M | 1.13% | 45,326 | 116.59M |
| 198 | DRTS | Alpha Tau Medical Ltd. | 702.32M | -1.60% | 114,284 | - |
| 199 | TENX | Tenax Therapeutics, Inc. | 698.17M | -1.56% | 202,791 | - |
| 200 | ARVN | Arvinas, Inc. | 685.66M | -0.83% | 300,577 | 262.60M |
| 201 | PRME | Prime Medicine, Inc. | 677.33M | -1.67% | 1,292,790 | 4.63M |
| 202 | PROK | ProKidney Corp. | 632.51M | -0.24% | 346,263 | 893.00K |
| 203 | EIKN | Eikon Therapeutics, Inc. | 626.38M | 0.17% | 76,913 | - |
| 204 | ANL | Adlai Nortye Ltd. | 625.40M | -5.81% | 240,036 | 5.00M |
| 205 | ZVRA | Zevra Therapeutics, Inc. | 621.17M | -1.86% | 439,448 | 106.47M |
| 206 | KYTX | Kyverna Therapeutics, Inc. | 612.57M | -10.04% | 859,863 | - |
| 207 | OCGN | Ocugen, Inc. | 604.84M | -3.24% | 2,718,999 | 4.41M |
| 208 | RIGL | Rigel Pharmaceuticals, Inc. | 602.04M | 0.31% | 102,001 | 294.28M |
| 209 | STTK | Shattuck Labs, Inc. | 594.83M | -0.13% | 221,514 | 1.00M |
| 210 | ABSI | Absci Corporation | 591.43M | -2.15% | 4,016,118 | 2.80M |
| 211 | CRMD | CorMedix Inc. | 589.72M | -1.58% | 405,341 | 311.71M |
| 212 | ACRS | Aclaris Therapeutics, Inc. | 583.78M | -1.18% | 1,000,637 | 7.83M |
| 213 | PRTA | Prothena Corporation plc | 573.86M | -1.20% | 257,324 | 9.68M |
| 214 | ENGN | enGene Therapeutics Inc. | 573.43M | 0.35% | 92,640 | - |
| 215 | STRO | Sutro Biopharma, Inc. | 571.16M | -0.30% | 128,858 | 102.48M |
| 216 | LYEL | Lyell Immunopharma, Inc. | 558.83M | -3.76% | 52,708 | 36.00K |
| 217 | ARMP | Armata Pharmaceuticals, Inc. | 542.17M | 18.40% | 97,212 | 4.90M |
| 218 | ADCT | ADC Therapeutics SA | 541.83M | 0.24% | 440,612 | 81.36M |
| 219 | AGMB | AgomAb Therapeutics NV | 535.62M | 1.85% | 62,900 | - |
| 220 | VALN | Valneva SE | 535.43M | -0.99% | 69,560 | 205.07M |
| 221 | VSTM | Verastem, Inc. | 531.45M | -7.21% | 793,942 | 30.91M |
| 222 | TECX | Tectonic Therapeutic, Inc. | 530.06M | -1.84% | 111,299 | - |
| 223 | IMMX | Immix Biopharma, Inc. | 521.11M | -2.58% | 282,861 | - |
| 224 | CADL | Candel Therapeutics, Inc. | 519.32M | -1.80% | 2,714,443 | - |
| 225 | UPB | Upstream Bio, Inc. | 512.64M | -5.71% | 200,228 | 2.85M |
| 226 | FULC | Fulcrum Therapeutics, Inc. | 511.49M | -3.27% | 333,890 | 80.00M |
| 227 | FDMT | 4D Molecular Therapeutics, Inc. | 504.39M | -1.89% | 250,548 | 85.21M |
| 228 | LRMR | Larimar Therapeutics, Inc. | 494.48M | -1.04% | 474,238 | - |
| 229 | ZURA | Zura Bio Limited | 491.48M | -3.54% | 348,649 | - |
| 230 | CTNM | Contineum Therapeutics, Inc. | 490.04M | -2.56% | 53,428 | - |
| 231 | DNA | Ginkgo Bioworks Holdings, Inc. | 488.07M | 5.08% | 925,654 | 170.16M |
| 232 | MDXG | MiMedx Group, Inc. | 486.56M | 0.77% | 1,189,738 | 418.63M |
| 233 | RGNX | REGENXBIO Inc. | 475.39M | -2.75% | 303,438 | 170.44M |
| 234 | AURA | Aura Biosciences, Inc. | 473.43M | 4.68% | 204,228 | - |
| 235 | TRDA | Entrada Therapeutics, Inc. | 472.68M | -3.17% | 40,579 | 25.42M |
| 236 | XOMA | XOMA Royalty Corporation | 471.39M | -1.10% | 67,413 | 52.15M |
| 237 | CLYM | Climb Bio, Inc. | 469.09M | 9.48% | 398,472 | - |
| 238 | LXEO | Lexeo Therapeutics, Inc. | 467.49M | -3.37% | 242,653 | - |
| 239 | BNTC | Benitec Biopharma Inc. | 465.87M | -2.79% | 52,743 | - |
| 240 | VTVT | vTv Therapeutics Inc. | 458.04M | -2.23% | 11,201 | 17.00K |
| 241 | IVVD | Invivyd, Inc. | 455.31M | -4.17% | 656,398 | 53.43M |
| 242 | ALT | Altimmune, Inc. | 450.16M | -2.81% | 2,327,367 | 41.00K |
| 243 | EPRX | Eupraxia Pharmaceuticals Inc. | 446.04M | -0.69% | 123,882 | - |
| 244 | PALI | Palisade Bio, Inc. | 438.64M | 4.80% | 6,071,847 | - |
| 245 | PRTC | PureTech Health plc | 436.98M | -2.02% | 746 | 6.39M |
| 246 | AVIR | Atea Pharmaceuticals, Inc. | 435.01M | -4.38% | 62,653 | - |
| 247 | ASMB | Assembly Biosciences, Inc. | 424.96M | -4.76% | 108,535 | 72.30M |
| 248 | IPSC | Century Therapeutics, Inc. | 424.15M | 0.85% | 523,735 | 109.16M |
| 249 | NMRA | Neumora Therapeutics, Inc. | 420.51M | 5.48% | 1,077,713 | - |
| 250 | LCTX | Lineage Cell Therapeutics, Inc. | 417.22M | 1.52% | 515,953 | 14.56M |
| 251 | NGNE | Neurogene Inc. | 416.92M | -3.50% | 68,382 | 925.00K |
| 252 | AUTL | Autolus Therapeutics plc | 410.18M | -2.46% | 672,184 | 75.39M |
| 253 | RCKT | Rocket Pharmaceuticals, Inc. | 405.94M | -3.63% | 998,424 | - |
| 254 | VNDA | Vanda Pharmaceuticals Inc. | 404.30M | -2.15% | 483,307 | 216.11M |
| 255 | PRLD | Prelude Therapeutics Incorporated | 394.51M | 5.99% | 252,250 | 12.14M |
| 256 | IRD | Opus Genetics, Inc. | 393.45M | -0.18% | 230,854 | 14.20M |
| 257 | ENTA | Enanta Pharmaceuticals, Inc. | 391.04M | -2.21% | 37,566 | 66.98M |
| 258 | NAGE | Niagen Bioscience, Inc. | 384.39M | -1.64% | 332,491 | 129.42M |
| 259 | XFOR | X4 Pharmaceuticals, Inc. | 382.77M | 0.48% | 145,907 | 35.11M |
| 260 | AVTX | Avalo Therapeutics, Inc. | 382.28M | -2.39% | 244,622 | 59.00K |
| 261 | SRZN | Surrozen, Inc. | 381.59M | 3.01% | 86,702 | 3.48M |
| 262 | OVID | Ovid Therapeutics Inc. | 378.48M | -0.69% | 1,533,643 | 7.25M |
| 263 | PBYI | Puma Biotechnology, Inc. | 368.35M | -1.76% | 70,202 | 228.37M |
| 264 | IMRX | Immuneering Corporation | 367.23M | 2.71% | 514,182 | - |
| 265 | SLN | Silence Therapeutics plc | 366.54M | -2.14% | 415,718 | 559.00K |
| 266 | YDES | YD Bio Limited | 357.93M | -4.14% | 28,694 | 510.36K |
| 267 | CABA | Cabaletta Bio, Inc. | 356.23M | -3.18% | 1,953,673 | - |
| 268 | MNPR | Monopar Therapeutics Inc. | 356.22M | -2.69% | 123,329 | - |
| 269 | NAUT | Nautilus Biotechnology, Inc. | 350.58M | -6.42% | 196,271 | - |
| 270 | BCYC | Bicycle Therapeutics plc | 348.54M | -5.48% | 396,934 | 72.59M |
| 271 | DMAC | DiaMedica Therapeutics Inc. | 340.54M | -3.66% | 53,805 | - |
| 272 | AVXL | Anavex Life Sciences Corp. | 333.62M | -1.37% | 420,853 | - |
| 273 | RZLT | Rezolute, Inc. | 332.91M | -4.90% | 529,029 | - |
| 274 | EDIT | Editas Medicine, Inc. | 328.85M | -5.88% | 1,044,340 | 40.52M |
| 275 | GLSI | Greenwich LifeSciences, Inc. | 319.62M | -5.91% | 122,772 | - |
| 276 | LENZ | LENZ Therapeutics, Inc. | 317.46M | -0.05% | 201,524 | 19.09M |
| 277 | NGEN | NervGen Pharma Corp. | 317.25M | -2.00% | 76,871 | - |
| 278 | NERV | Minerva Neurosciences, Inc. | 316.10M | 4.64% | 114,509 | - |
| 279 | FHTX | Foghorn Therapeutics Inc. | 313.75M | -2.99% | 44,435 | 30.91M |
| 280 | ABEO | Abeona Therapeutics Inc. | 309.78M | -0.91% | 363,979 | 5.82M |
| 281 | ELDN | Eledon Pharmaceuticals, Inc. | 304.62M | -3.14% | 1,575,095 | - |
| 282 | ARTV | Artiva Biotherapeutics, Inc. | 300.55M | -9.19% | 308,336 | 251.00K |
| 283 | CCCC | C4 Therapeutics, Inc. | 296.15M | 1.51% | 1,795,668 | 35.95M |
| 284 | NBP | NovaBridge Biosciences | 294.33M | -3.96% | 345,412 | - |
| 285 | CLLS | Cellectis S.A. | 292.82M | -2.44% | 29,245 | 79.59M |
| 286 | ACIU | AC Immune SA | 287.68M | -2.68% | 53,339 | 4.51M |
| 287 | IKT | Inhibikase Therapeutics, Inc. | 286.31M | -7.18% | 1,629,127 | 1.00 |
| 288 | CHRS | Coherus Oncology, Inc. | 284.53M | -7.29% | 1,479,359 | 42.17M |
| 289 | ZNTL | Zentalis Pharmaceuticals, Inc. | 283.01M | -0.99% | 754,280 | 26.87M |
| 290 | TARA | Protara Therapeutics, Inc. | 279.62M | -2.45% | 461,891 | - |
| 291 | ALEC | Alector, Inc. | 279.22M | -6.47% | 166,368 | 21.05M |
| 292 | CGEN | Compugen Ltd. | 269.48M | -1.04% | 208,815 | 72.76M |
| 293 | SABS | SAB Biotherapeutics, Inc. | 260.02M | -4.15% | 249,538 | 114.70K |
| 294 | ADAG | Adagene Inc. | 257.68M | 0.26% | 180,692 | 7.67M |
| 295 | HELP | Cybin Inc. | 254.68M | -9.27% | 2,130,683 | - |
| 296 | ARCT | Arcturus Therapeutics Holdings Inc. | 251.83M | -0.45% | 188,798 | 82.03M |
| 297 | OBIO | Orchestra BioMed Holdings, Inc. | 251.64M | -1.15% | 69,250 | 33.48M |
| 298 | VYGR | Voyager Therapeutics, Inc. | 250.02M | -0.83% | 215,971 | 40.37M |
| 299 | PLYX | Polaryx Therapeutics, Inc. | 247.13M | -8.42% | 739,226 | - |
| 300 | NKTX | Nkarta, Inc. | 242.74M | -2.44% | 488,617 | - |
| 301 | SLGL | Sol-Gel Technologies Ltd. | 241.58M | 5.57% | 11,041 | 19.39M |
| 302 | CAMP | Camp4 Therapeutics Corporation | 239.09M | 2.11% | 13,961 | 3.50M |
| 303 | MIST | Milestone Pharmaceuticals Inc. | 238.55M | -4.66% | 1,279,595 | 1.55M |
| 304 | FENC | Fennec Pharmaceuticals Inc. | 228.57M | -1.49% | 28,560 | 44.64M |
| 305 | ALXO | ALX Oncology Holdings Inc. | 228.34M | -0.86% | 366,469 | - |
| 306 | ELTX | Elicio Therapeutics, Inc. | 225.54M | 0.49% | 71,060 | - |
| 307 | KROS | Keros Therapeutics, Inc. | 223.99M | -2.57% | 147,956 | 244.06M |
| 308 | NVCT | Nuvectis Pharma, Inc. | 223.99M | 1.50% | 22,056 | - |
| 309 | MGNX | MacroGenics, Inc. | 223.41M | 1.01% | 464,736 | 149.50M |
| 310 | CDXS | Codexis, Inc. | 220.81M | -7.25% | 889,721 | 70.39M |
| 311 | CRBU | Caribou Biosciences, Inc. | 220.33M | -0.44% | 1,538,678 | 11.16M |
| 312 | ACHV | Achieve Life Sciences, Inc. | 219.35M | -3.06% | 1,132,634 | - |
| 313 | OABI | OmniAb, Inc. | 218.62M | -2.58% | 234,434 | 18.67M |
| 314 | MDWD | MediWound Ltd. | 215.15M | -3.52% | 20,711 | 16.96M |
| 315 | CNTX | Context Therapeutics Inc. | 215.00M | 3.54% | 812,680 | - |
| 316 | ENLV | Enlivex Ltd. | 210.63M | 1.30% | 348,046 | - |
| 317 | KPTI | Karyopharm Therapeutics Inc. | 208.53M | 3.47% | 738,953 | 146.07M |
| 318 | ABOS | Acumen Pharmaceuticals, Inc. | 198.95M | -2.99% | 149,367 | - |
| 319 | WHWK | Whitehawk Therapeutics, Inc. | 198.23M | -0.71% | 55,746 | 7.15M |
| 320 | HRTX | Heron Therapeutics, Inc. | 197.96M | - | 1,916,221 | 154.90M |
| 321 | SGMT | Sagimet Biosciences Inc. | 197.47M | -5.90% | 343,453 | - |
| 322 | TNXP | Tonix Pharmaceuticals Holding Corp. | 197.46M | -3.07% | 176,524 | 13.11M |
| 323 | KRRO | Korro Bio, Inc. | 197.30M | -4.20% | 38,631 | 6.39M |
| 324 | DTIL | Precision BioSciences, Inc. | 191.72M | -1.98% | 86,040 | 34.26M |
| 325 | CNTN | Canton Strategic Holdings, Inc. | 191.50M | -3.70% | 232,149 | - |
| 326 | RNAC | Cartesian Therapeutics, Inc. | 188.48M | 2.45% | 80,885 | 2.80M |
| 327 | PRQR | ProQR Therapeutics N.V. | 187.02M | -3.53% | 342,726 | 19.19M |
| 328 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | 184.46M | -2.07% | 123,372 | - |
| 329 | UNCY | Unicycive Therapeutics, Inc. | 182.97M | -2.42% | 307,661 | - |
| 330 | BDTX | Black Diamond Therapeutics, Inc. | 182.18M | 4.26% | 765,861 | 70.00M |
| 331 | PLX | Protalix BioTherapeutics, Inc. | 180.48M | -1.32% | 312,750 | 52.74M |
| 332 | KALA | KALA BIO, Inc. | 180.32M | -3.00% | 3,734,442 | - |
| 333 | HURA | TuHURA Biosciences, Inc. | 173.89M | -3.36% | 835,713 | - |
| 334 | MENS | Jyong Biotech Ltd. | 173.03M | -2.60% | 61,985 | - |
| 335 | MOLN | Molecular Partners AG | 165.88M | -3.63% | 887 | 856.30K |
| 336 | SPRO | Spero Therapeutics, Inc. | 162.39M | -1.23% | 180,992 | 66.80M |
| 337 | FATE | Fate Therapeutics, Inc. | 156.96M | -2.88% | 767,040 | 6.65M |
| 338 | ORMP | Oramed Pharmaceuticals Inc. | 155.72M | 0.52% | 81,276 | 2.00M |
| 339 | REPL | Replimune Group, Inc. | 155.65M | -8.94% | 4,022,926 | - |
| 340 | AGEN | Agenus Inc. | 155.51M | -8.37% | 969,062 | 114.20M |
| 341 | TLSA | Tiziana Life Sciences Ltd | 153.79M | -0.41% | 63,492 | - |
| 342 | GALT | Galectin Therapeutics Inc. | 152.72M | 1.31% | 211,507 | - |
| 343 | TNYA | Tenaya Therapeutics, Inc. | 151.90M | -5.58% | 3,985,808 | - |
| 344 | CNTB | Connect Biopharma Holdings Limited | 151.48M | - | 235,611 | 64.00K |
| 345 | ACOG | Alpha Cognition Inc. | 151.11M | 0.73% | 34,145 | 10.22M |
| 346 | HUMA | Humacyte, Inc. | 148.31M | -2.84% | 3,134,720 | 2.04M |
| 347 | KLRS | Kalaris Therapeutics, Inc. | 144.45M | -4.55% | 33,509 | - |
| 348 | IPHA | Innate Pharma S.A. | 143.68M | -5.03% | 6,237 | 10.57M |
| 349 | BMEA | Biomea Fusion, Inc. | 138.81M | -6.34% | 998,558 | - |
| 350 | EQ | Equillium, Inc. | 135.94M | 6.97% | 185,207 | 4.39M |
| 351 | ANTX | AN2 Therapeutics, Inc. | 132.25M | 1.52% | 84,623 | - |
| 352 | ONCY | Oncolytics Biotech Inc. | 129.48M | 0.45% | 462,767 | - |
| 353 | NTHI | NeOnc Technologies Holdings, Inc. | 128.67M | - | 16,976 | 39.99K |
| 354 | IFRX | InflaRx N.V. | 124.34M | 3.61% | 789,608 | 34.44K |
| 355 | AARD | Aardvark Therapeutics, Inc. | 119.44M | -3.10% | 110,102 | - |
| 356 | IMUX | Immunic, Inc. | 118.61M | -4.81% | 1,748,424 | - |
| 357 | VANI | Vivani Medical, Inc. | 118.51M | -7.28% | 449,107 | - |
| 358 | CBUS | Cibus, Inc. | 118.45M | -0.32% | 206,935 | 3.64M |
| 359 | CRDF | Cardiff Oncology, Inc. | 116.22M | -4.49% | 607,516 | 593.00K |
| 360 | KZIA | Kazia Therapeutics Limited | 115.64M | -3.53% | 164,743 | 1.27M |
| 361 | GNLX | Genelux Corporation | 115.15M | -2.08% | 138,230 | 8.00K |
| 362 | PEPG | PepGen Inc. | 114.73M | -4.05% | 389,265 | - |
| 363 | SEER | Seer, Inc. | 113.41M | 1.01% | 264,181 | 16.58M |
| 364 | VRCA | Verrica Pharmaceuticals Inc. | 109.94M | 0.31% | 41,711 | 35.58M |
| 365 | COYA | Coya Therapeutics, Inc. | 109.78M | -6.21% | 195,580 | 7.95M |
| 366 | PYXS | Pyxis Oncology, Inc. | 107.13M | 0.29% | 128,172 | 13.86M |
| 367 | SGMO | Sangamo Therapeutics, Inc. | 106.55M | -4.78% | 3,713,985 | 39.55M |
| 368 | CGTX | Cognition Therapeutics, Inc. | 105.44M | 5.36% | 3,158,118 | - |
| 369 | ALDX | Aldeyra Therapeutics, Inc. | 103.82M | -3.09% | 695,834 | - |
| 370 | ANIX | Anixa Biosciences, Inc. | 98.57M | -2.00% | 83,470 | - |
| 371 | PMN | ProMIS Neurosciences, Inc. | 98.20M | -4.33% | 30,503 | - |
| 372 | RANI | Rani Therapeutics Holdings, Inc. | 97.17M | 0.08% | 422,261 | 1.63M |
| 373 | COEP | Coeptis Therapeutics Holdings, Inc. | 96.15M | -0.58% | 79,736 | 1.36M |
| 374 | NRXP | NRx Pharmaceuticals, Inc. | 96.13M | -9.06% | 1,961,463 | 1.23M |
| 375 | TTRX | Turn Therapeutics Inc. | 95.32M | -5.33% | 13,436 | - |
| 376 | INO | Inovio Pharmaceuticals, Inc. | 93.00M | -3.81% | 1,517,745 | 65.34K |
| 377 | QTTB | Q32 Bio Inc. | 92.68M | -4.74% | 433,453 | 53.74M |
| 378 | GUTS | Fractyl Health, Inc. | 91.65M | 0.38% | 1,802,208 | 3.00K |
| 379 | GANX | Gain Therapeutics, Inc. | 89.98M | 0.47% | 356,338 | - |
| 380 | PYPD | PolyPid Ltd. | 88.16M | -1.49% | 33,289 | - |
| 381 | EXOZ | eXoZymes, Inc. | 87.72M | -2.95% | 755 | -700.00 |
| 382 | GOSS | Gossamer Bio, Inc. | 87.32M | -11.42% | 5,355,418 | 48.47M |
| 383 | ACET | Adicet Bio, Inc. | 86.75M | -6.92% | 81,890 | - |
| 384 | LONA | LeonaBio, Inc. | 86.19M | -2.19% | 16,722 | - |
| 385 | ATHE | Alterity Therapeutics Limited | 85.80M | -5.83% | 21,222 | 4.43M |
| 386 | MCRB | Seres Therapeutics, Inc. | 83.35M | -2.74% | 14,725 | 789.00K |
| 387 | CSBR | Champions Oncology, Inc. | 83.18M | -1.40% | 1,618 | 57.95M |
| 388 | OKYO | OKYO Pharma Limited | 82.39M | -1.26% | 12,069 | - |
| 389 | FLNA | Filana Therapeutics, Inc. | 82.12M | -2.86% | 197,402 | - |
| 390 | NRXS | NeurAxis, Inc. | 81.33M | 3.86% | 67,502 | 3.57M |
| 391 | ATYR | aTyr Pharma, Inc. | 80.96M | -3.22% | 413,390 | 190.00K |
| 392 | MAIA | MAIA Biotechnology, Inc. | 80.69M | -5.68% | 274,305 | - |
| 393 | ESLA | Estrella Immunopharma, Inc. | 80.21M | 3.87% | 10,625 | - |
| 394 | PLRX | Pliant Therapeutics, Inc. | 78.63M | -1.55% | 568,449 | - |
| 395 | PMVP | PMV Pharmaceuticals, Inc. | 77.86M | 2.10% | 239,287 | - |
| 396 | XBIT | XBiotech Inc. | 77.44M | 1.20% | 15,786 | - |
| 397 | IMMP | Immutep Limited | 77.16M | -1.67% | 2,895,227 | 5.28M |
| 398 | PTHS | Pelthos Therapeutics Inc. | 76.99M | -0.02% | 12,323 | 16.80M |
| 399 | TCRX | TScan Therapeutics, Inc. | 76.63M | -10.84% | 1,036,582 | 10.33M |
| 400 | PDSB | PDS Biotechnology Corporation | 73.68M | 2.33% | 629,381 | - |
| 401 | FBIO | Fortress Biotech, Inc. | 72.46M | -3.02% | 225,341 | 63.26M |
| 402 | IBO | Impact BioMedical Inc. | 72.24M | -1.47% | 69,181 | 32.00K |
| 403 | SPRB | Spruce Biosciences, Inc. | 72.04M | -24.89% | 505,360 | 697.00K |
| 404 | MNOV | MediciNova, Inc. | 71.86M | -0.68% | 16,774 | 409.66K |
| 405 | BYSI | BeyondSpring Inc. | 71.55M | -1.99% | 3,966 | 1.88M |
| 406 | ICCC | ImmuCell Corporation | 71.47M | -1.50% | 1,270 | 27.64M |
| 407 | GRCE | Grace Therapeutics, Inc. | 70.56M | -0.65% | 412,622 | - |
| 408 | ACRV | Acrivon Therapeutics, Inc. | 68.97M | -4.30% | 295,711 | - |
| 409 | CING | Cingulate Inc. | 68.61M | -2.16% | 616,890 | - |
| 410 | OKUR | OnKure Therapeutics, Inc. | 67.34M | -1.30% | 38,646 | - |
| 411 | IBIO | iBio, Inc. | 67.01M | -1.52% | 248,166 | 300.00K |
| 412 | EDSA | Edesa Biotech, Inc. | 65.75M | 9.63% | 247,075 | - |
| 413 | IMA | ImageneBio, Inc. | 64.54M | -3.83% | 17,656 | 800.00K |
| 414 | ANVS | Annovis Bio, Inc. | 64.23M | -3.12% | 661,955 | - |
| 415 | HYFT | MindWalk Holdings Corp. | 62.08M | -1.57% | 134,594 | 20.70M |
| 416 | CUE | Cue Biopharma, Inc. | 61.82M | -25.49% | 12,256,038 | 27.47M |
| 417 | INKT | MiNK Therapeutics, Inc. | 58.10M | -8.74% | 52,614 | - |
| 418 | OSTX | OS Therapies Incorporated | 57.38M | -1.09% | 188,136 | - |
| 419 | MGX | Metagenomi Therapeutics, Inc. | 56.81M | -1.31% | 96,370 | 25.21M |
| 420 | ACTU | Actuate Therapeutics, Inc. | 56.20M | -9.54% | 270,671 | - |
| 421 | TIL | Instil Bio, Inc. | 55.20M | -3.00% | 7,781 | - |
| 422 | ENTX | Entera Bio Ltd. | 55.01M | -11.94% | 164,141 | 42.00K |
| 423 | KZR | Kezar Life Sciences, Inc. | 53.93M | 0.14% | 47,128 | - |
| 424 | RADX | Radiopharm Theranostics Limited | 53.38M | -2.92% | 46,550 | 10.86M |
| 425 | MREO | Mereo BioPharma Group plc | 51.84M | -3.64% | 536,592 | 500.00K |
| 426 | NTRB | Nutriband Inc. | 50.81M | -0.47% | 839 | 2.28M |
| 427 | DWTX | Dogwood Therapeutics, Inc. | 50.77M | -5.00% | 65,727 | - |
| 428 | ATOS | Atossa Therapeutics, Inc. | 50.46M | -5.02% | 57,372 | - |
| 429 | RNTX | Rein Therapeutics Inc. | 49.21M | -4.10% | 92,813 | - |
| 430 | TELO | Telomir Pharmaceuticals, Inc. | 48.82M | -4.05% | 43,257 | - |
| 431 | XLO | Xilio Therapeutics, Inc. | 48.43M | -0.89% | 21,692 | 43.77M |
| 432 | PSTV | Plus Therapeutics, Inc. | 48.24M | -3.70% | 281,278 | 5.21M |
| 433 | ATNM | Actinium Pharmaceuticals, Inc. | 46.14M | 2.78% | 442,075 | 90.00K |
| 434 | HOWL | Werewolf Therapeutics, Inc. | 44.89M | -4.73% | 181,295 | 1.14M |
| 435 | HYPD | Hyperion DeFi, Inc. | 44.66M | -8.41% | 205,330 | 813.46K |
| 436 | RLYB | Rallybio Corporation | 43.75M | -0.24% | 14,429 | 858.00K |
| 437 | RNXT | RenovoRx, Inc. | 41.90M | -7.45% | 548,784 | 1.12M |
| 438 | LITS | Lite Strategy, Inc. | 41.45M | -4.20% | 335,097 | - |
| 439 | ALGS | Aligos Therapeutics, Inc. | 41.03M | 1.84% | 199,402 | 2.19M |
| 440 | ATRA | Atara Biotherapeutics, Inc. | 40.89M | 0.20% | 25,859 | 120.77M |
| 441 | SNSE | Sensei Biotherapeutics, Inc. | 40.14M | -4.59% | 9,107 | - |
| 442 | NXTC | NextCure, Inc. | 39.20M | -5.90% | 82,269 | - |
| 443 | PTN | Palatin Technologies, Inc. | 39.18M | 1.95% | 7,122 | 8.96M |
| 444 | LIXT | Lixte Biotechnology Holdings, Inc. | 38.34M | -3.93% | 7,428 | - |
| 445 | VERU | Veru Inc. | 38.04M | -2.47% | 13,134 | 16.89M |
| 446 | CRVO | CervoMed Inc. | 37.31M | 1.51% | 42,010 | 4.01M |
| 447 | INMB | INmune Bio Inc. | 37.22M | -6.04% | 240,856 | 50.00K |
| 448 | DARE | Daré Bioscience, Inc. | 36.54M | -12.54% | 1,006,241 | 1.03M |
| 449 | EVAX | Evaxion A/S | 36.11M | -3.56% | 16,398 | 7.53M |
| 450 | CELU | Celularity Inc. | 36.05M | 0.81% | 33,449 | 40.58M |
| 451 | PLUR | Pluri Inc. | 35.68M | -1.12% | 2,311 | 1.34M |
| 452 | BOLD | Boundless Bio, Inc. | 35.52M | -0.94% | 58,791 | - |
| 453 | SNTI | Senti Biosciences, Inc. | 33.95M | -4.39% | 242,128 | 22.00K |
| 454 | TVGN | Tevogen Bio Holdings Inc. | 33.31M | -3.61% | 64,893 | - |
| 455 | OTLK | Outlook Therapeutics, Inc. | 32.90M | -15.00% | 8,440,676 | 205.70K |
| 456 | CVM | CEL-SCI Corporation | 31.56M | -1.02% | 32,710 | - |
| 457 | IGC | IGC Pharma, Inc. | 30.83M | 0.88% | 1,776,996 | 1.11M |
| 458 | ABVC | ABVC BioPharma, Inc. | 30.64M | -4.62% | 28,637 | 797.92K |
| 459 | DYAI | Dyadic International, Inc. | 30.42M | -5.04% | 76,724 | 3.09M |
| 460 | LGVN | Longeveron Inc. | 29.57M | -2.88% | 665,113 | 1.20M |
| 461 | TVRD | Tvardi Therapeutics, Inc. | 29.46M | -2.48% | 13,463 | - |
| 462 | BCTX | BriaCell Therapeutics Corp. | 29.16M | -2.49% | 247,126 | - |
| 463 | LTRN | Lantern Pharma Inc. | 29.14M | -5.80% | 105,267 | - |
| 464 | KYNB | Kyntra Bio, Inc. | 28.73M | -3.27% | 2,239 | 6.44M |
| 465 | LSTA | Lisata Therapeutics, Inc. | 28.27M | 10.60% | 141,554 | 170.00K |
| 466 | APLM | Apollomics, Inc. | 28.17M | -3.03% | 6,148 | 6.93M |
| 467 | AEON | AEON Biopharma, Inc. | 28.09M | 3.74% | 76,928 | - |
| 468 | JSPR | Jasper Therapeutics, Inc. | 27.12M | -8.60% | 274,758 | - |
| 469 | NNVC | NanoViricides, Inc. | 26.99M | -2.34% | 282,330 | - |
| 470 | NEUP | Neuphoria Therapeutics Inc. | 26.52M | -2.19% | 22,161 | 14.99M |
| 471 | TPST | Tempest Therapeutics, Inc. | 26.39M | -5.15% | 148,981 | - |
| 472 | SKYE | Skye Bioscience, Inc. | 26.38M | 0.89% | 110,326 | - |
| 473 | MRKR | Marker Therapeutics, Inc. | 26.26M | -5.69% | 46,558 | 3.55M |
| 474 | BRNS | Barinthus Biotherapeutics plc | 24.51M | 1.69% | 17,262 | 14.97M |
| 475 | SER | Serina Therapeutics, Inc. | 24.26M | -6.19% | 58,761 | 130.00K |
| 476 | NRSN | NeuroSense Therapeutics Ltd. | 24.14M | -3.80% | 57,463 | - |
| 477 | XCUR | Exicure, Inc. | 23.97M | -0.21% | 5,761 | 500.00K |
| 478 | VTGN | Vistagen Therapeutics, Inc. | 23.91M | -0.87% | 279,716 | 789.00K |
| 479 | LEXX | Lexaria Bioscience Corp. | 23.39M | -5.07% | 233,107 | 368.00K |
| 480 | CRIS | Curis, Inc. | 23.37M | -5.25% | 407,240 | 9.44M |
| 481 | PBM | Psyence Biomedical Ltd. | 22.25M | -14.16% | 3,614,978 | - |
| 482 | PLRZ | Polyrizon Ltd. | 22.02M | 6.10% | 226,105 | - |
| 483 | QNCX | Quince Therapeutics, Inc. | 21.84M | 5.51% | 1,295,658 | - |
| 484 | ALLR | Allarity Therapeutics, Inc. | 21.51M | 8.80% | 361,479 | 320.00K |
| 485 | VYNE | VYNE Therapeutics Inc. | 21.33M | 1.07% | 114,487 | 570.00K |
| 486 | TRAW | Traws Pharma, Inc. | 20.01M | -10.79% | 139,099 | 2.79M |
| 487 | COCP | Cocrystal Pharma, Inc. | 19.75M | -5.14% | 102,555 | - |
| 488 | PASG | Passage Bio, Inc. | 19.47M | -2.88% | 338,466 | - |
| 489 | OSRH | OSR Holdings, Inc. | 19.38M | -2.48% | 353,259 | 2.91M |
| 490 | CTXR | Citius Pharmaceuticals, Inc. | 19.02M | -2.77% | 270,562 | 3.94M |
| 491 | QNTM | Quantum BioPharma Ltd. | 17.94M | 5.45% | 1,011,690 | - |
| 492 | KTTA | Pasithea Therapeutics Corp. | 17.44M | -2.50% | 343,845 | - |
| 493 | ICU | SeaStar Medical Holding Corporation | 17.13M | -7.34% | 50,145 | 1.23M |
| 494 | JUNS | Jupiter Neurosciences, Inc. | 17.05M | 2.15% | 27,975 | 21.80K |
| 495 | LPCN | Lipocine Inc. | 17.01M | 1.30% | 240,333 | 1.98M |
| 496 | GNTA | Genenta Science S.p.A. | 16.51M | -0.14% | 33,916 | - |
| 497 | TOVX | Theriva Biologics, Inc. | 16.11M | -14.37% | 46,217,063 | - |
| 498 | CDT | CDT Equity Inc. | 15.96M | -2.09% | 25,170 | - |
| 499 | HIND | Vyome Holdings, Inc. | 15.94M | -3.34% | 15,787 | 319.71K |
| 500 | NCEL | NewcelX Ltd. | 15.36M | 19.08% | 178,911 | - |